Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
K Miyamoto1, N Seki2, R Matsushita1
1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Background:
Previous studies have revealed that miR-26a-5p and miR-26b-5p act as tumour suppressors in various types of cancer tissues. Here, we aimed to investigate the functional roles of these miRNAs and to identify their regulatory targets in bladder cancer (BC).
Methods:
We performed functional assays in BC cells using transfection of mature microRNAs (miRNAs). In silico and luciferase reporter analyses were applied to identify target genes of these miRNAs. The overall survival (OS) of patients with BC was evaluated by the Kaplan-Meier method.
Results:
miR-26a-5p and miR-26b-5p were significantly downregulated in BC tissues. Restoration of these miRNAs inhibited cell migration and invasion in BC. The gene encoding procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a collagen crosslinking enzyme, was directly regulated by miR-26a-5p and miR-26b-5p. Kaplan-Meier analysis revealed that patients with high PLOD2 expression had significantly shorter OS compared with those with low PLOD2 expression (P=0.0153).
Conclusions:
PLOD2, which is associated with the stiffness of the extracellular matrix, was directly regulated by miR-26a-5p and miR-26b-5p and may be a good prognostic marker in patients with BC.
Insights
MicroRNAs miR-26a-5p and miR-26b-5p are downregulated in bladder cancer (BC). Their restoration inhibits BC cell invasion, and PLOD2 is identified as a direct target, serving as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) miR-26a-5p and miR-26b-5p are recognized as tumor suppressors in multiple cancers.
- Their specific roles and regulatory targets in bladder cancer (BC) remain to be fully elucidated.
Purpose of the Study:
- To investigate the functional significance of miR-26a-5p and miR-26b-5p in bladder cancer.
- To identify the direct molecular targets regulated by these miRNAs in BC.
Main Methods:
- Functional assays were conducted in bladder cancer cell lines following miRNA transfection.
- In silico analysis and luciferase reporter assays were employed to identify miRNA target genes.
- Kaplan-Meier analysis was used to assess the association between gene expression and overall survival (OS) in BC patients.
Main Results:
- miR-26a-5p and miR-26b-5p expression was significantly reduced in bladder cancer tissues.
- Reintroduction of these miRNAs suppressed bladder cancer cell migration and invasion.
- Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) was identified as a direct target gene.
- High PLOD2 expression correlated with significantly shorter overall survival in bladder cancer patients (P=0.0153).
Conclusions:
- PLOD2, an enzyme involved in extracellular matrix stiffness, is directly regulated by miR-26a-5p and miR-26b-5p.
- PLOD2 may serve as a valuable prognostic biomarker for bladder cancer patients.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Drugs that Stabilize Microtubules

